Hans-Henrik Parving
Overview
Explore the profile of Hans-Henrik Parving including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
275
Citations
13652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Waijer S, de Vries S, Busch R, Xie D, Gansevoort R, Hou F, et al.
J Am Soc Nephrol
. 2021 Aug;
32(11):2731-2734.
PMID: 34417318
No abstract available.
12.
Abitz Winther S, Ollgaard J, Hansen T, von Scholten B, Reinhard H, Ahluwalia T, et al.
PLoS One
. 2021 Mar;
16(3):e0244402.
PMID: 33657115
Aims: The trimethylamine N-oxide (TMAO) pathway is related to intestinal microbiota and has been associated to risk of cardiovascular disease (CVD). We investigated associations between four plasma metabolites in the...
13.
Koomen J, Stevens J, Bakris G, Correa-Rotter R, Hou F, Kitzman D, et al.
Clin Pharmacol Ther
. 2020 Dec;
109(6):1631-1638.
PMID: 33338269
Atrasentan, an endothelin receptor antagonist, showed clinically significant albuminuria reduction with minimal signs of fluid retention in phase II trials. We evaluated whether plasma exposure was associated with long-term outcomes...
14.
Koomen J, Stevens J, Bakris G, Correa-Rotter R, Hou F, Kitzman D, et al.
Diabetes Obes Metab
. 2020 Nov;
23(2):561-568.
PMID: 33184931
Aim: To evaluate whether atrasentan plasma exposure explains between-patient variability in urinary albumin-to-creatinine ratio (UACR) response, a surrogate for kidney protection, and B-type natriuretic peptide (BNP) response, a surrogate for...
15.
Curovic V, Theilade S, Abitz Winther S, Tofte N, Tarnow L, Jorsal A, et al.
Diabet Med
. 2020 Nov;
38(5):e14459.
PMID: 33179275
Background: Clinical characteristics such as HbA , systolic blood pressure (SBP), albuminuria and estimated glomerular filtration rate (eGFR) are important when treating type 1 diabetes. We investigated the variability in...
16.
Malachias M, Jhund P, Claggett B, Wijkman M, Bentley-Lewis R, Chaturvedi N, et al.
J Am Heart Assoc
. 2020 Sep;
9(19):e017462.
PMID: 32964800
Background NT-proBNP (N-terminal pro-B-type natriuretic peptide) improves the discriminatory ability of risk-prediction models in type 2 diabetes mellitus (T2DM) but is not yet used in clinical practice. We assessed the...
17.
Winther S, Henriksen P, Vogt J, Hansen T, Ahonen L, Suvitaival T, et al.
Diabetologia
. 2020 Sep;
63(12):2713-2724.
PMID: 32886190
Aims/hypothesis: Abnormal gut microbiota and blood metabolome profiles have been reported both in children and adults with uncomplicated type 1 diabetes as well as in adults with type 1 diabetes...
18.
Heinrich N, von Scholten B, Reinhard H, Persson F, Ahluwalia T, Hansen T, et al.
J Diabetes Complications
. 2020 May;
34(7):107593.
PMID: 32349898
Aims: Lipoprotein(a)(Lp(a)) has emerged as an independent risk marker for cardiovascular disease (CVD) in the general population and among persons with existing CVD. We investigated associations between serum Lp(a)concentrations and...
19.
Heerspink H, Parving H, de Zeeuw D
Lancet
. 2020 Jan;
395(10220):270.
PMID: 31982067
No abstract available.
20.
Agesen R, Alibegovic A, Andersen H, Beck-Nielsen H, Gustenhoff P, Hansen T, et al.
BMC Endocr Disord
. 2019 Jul;
19(1):78.
PMID: 31337371
Background: Hypoglycaemia, especially nocturnal, remains the main limiting factor of achieving good glycaemic control in type 1 diabetes. The effect of first generation long-acting insulin analogues in reducing nocturnal hypoglycaemia...